Adike Abimbola, Karlin Nina, Menias Christine, Carey Elizabeth J
Division of Gastroenterology and Hepatology, Mayo Clinic Arizona, Phoenix, Ariz., USA.
Division of Hematology and Oncology, Mayo Clinic Arizona, Phoenix, Ariz., USA.
Case Rep Gastroenterol. 2016 Jul 29;10(2):381-391. doi: 10.1159/000448066. eCollection 2016 May-Aug.
Pseudocirrhosis describes morphological changes of the liver that closely mimic cirrhosis, without the typical histopathological changes seen in cirrhosis. It most commonly occurs in patients with metastatic breast cancer, although it has been reported in other malignancies as well. Like in cirrhosis, portal hypertension is often seen in patients with pseudocirrhosis. Pseudocirrhosis is a rare but important complication of metastatic cancer. In this case series and literature review, we describe 6 patients with hormone-receptor-positive metastatic breast cancer. We report the significant morbidity associated with pseudocirrhosis in the course of treatment in patients with metastatic breast cancer.
假性肝硬化描述的是肝脏的形态学改变,其与肝硬化极为相似,但没有肝硬化典型的组织病理学变化。它最常见于转移性乳腺癌患者,不过在其他恶性肿瘤中也有报道。与肝硬化一样,假性肝硬化患者常出现门静脉高压。假性肝硬化是转移性癌症一种罕见但重要的并发症。在本病例系列及文献综述中,我们描述了6例激素受体阳性转移性乳腺癌患者。我们报告了转移性乳腺癌患者在治疗过程中与假性肝硬化相关的显著发病率。